Am I adding this right. After all is done, VERB will have 70,304,920 shares outstanding?
I guess the good thing about this increase in OS is that the share price will have to be about three times higher for all the 13,509,038 warrant to be fully exercised.
Lets hope it doesn't take until 2024 to happen.
Nice start for the week.
The Offering
Securities offered by the selling security holders 3,338,141 shares of common stock upon exercise of outstanding Warrants.
Common stock outstanding prior to this offering 43,913,670 shares, as of August 5, 2020.
Common stock to be outstanding after this offering 47,251,811 shares, which gives effect to the shares of common stock offered under this prospectus.
The Nasdaq Capital Market symbol VERB
Use of Proceeds We will not receive any of the proceeds from the sale of the shares of common stock being offered under this prospectus. We will receive proceeds upon cash exercises, if any, of the Warrants. See “Use of Proceeds.”
Risk Factors There are many risks related to our business, this offering and ownership of the shares of common stock that you should consider before you decide to buy the shares of common stock in this offering. You should read the “Risk Factors” section beginning on page 6, as well as other cautionary statements throughout this prospectus, before investing the shares of common stock.
The number of shares of common stock that will be outstanding upon the completion of this offering is based on the 43,913,670 shares outstanding as of August 5, 2020, and excludes the following:
● 4,692,271 shares of common stock issuable upon the exercise of outstanding stock options as of August 5, 2020, with a weighted-average exercise price of $1.71 per share;
● 2,671,852 shares of common stock issuable under restricted stock awards as of August 5, 2020, with a weighted-average exercise price of $1.22 per share;
● 330,912 shares of common stock reserved for future issuance under our 2019 Omnibus Incentive Plan, or Incentive Plan;
● 13,509,038 shares of common stock issuable upon exercise of warrants to purchase common stock outstanding as of August 5, 2020, with a weighted-average exercise price of $2.49 per share;
● 1,849,036 shares of common stock issuable upon conversion of our Series A Convertible Preferred Stock, or Series A Preferred Stock; and
● any additional shares of common stock we may issue from time to time after that date.
Unless otherwise indicated, all information in this prospectus assumes the following:
● no exercise of outstanding options and warrants (including the Warrants); and
● no conversion of outstanding shares of our Series A Preferred Stock, or our convertible notes.
I guess the good thing about this increase in OS is that the share price will have to be about three times higher for all the 13,509,038 warrant to be fully exercised.
Lets hope it doesn't take until 2024 to happen.
Nice start for the week.
The Offering
Securities offered by the selling security holders 3,338,141 shares of common stock upon exercise of outstanding Warrants.
Common stock outstanding prior to this offering 43,913,670 shares, as of August 5, 2020.
Common stock to be outstanding after this offering 47,251,811 shares, which gives effect to the shares of common stock offered under this prospectus.
The Nasdaq Capital Market symbol VERB
Use of Proceeds We will not receive any of the proceeds from the sale of the shares of common stock being offered under this prospectus. We will receive proceeds upon cash exercises, if any, of the Warrants. See “Use of Proceeds.”
Risk Factors There are many risks related to our business, this offering and ownership of the shares of common stock that you should consider before you decide to buy the shares of common stock in this offering. You should read the “Risk Factors” section beginning on page 6, as well as other cautionary statements throughout this prospectus, before investing the shares of common stock.
The number of shares of common stock that will be outstanding upon the completion of this offering is based on the 43,913,670 shares outstanding as of August 5, 2020, and excludes the following:
● 4,692,271 shares of common stock issuable upon the exercise of outstanding stock options as of August 5, 2020, with a weighted-average exercise price of $1.71 per share;
● 2,671,852 shares of common stock issuable under restricted stock awards as of August 5, 2020, with a weighted-average exercise price of $1.22 per share;
● 330,912 shares of common stock reserved for future issuance under our 2019 Omnibus Incentive Plan, or Incentive Plan;
● 13,509,038 shares of common stock issuable upon exercise of warrants to purchase common stock outstanding as of August 5, 2020, with a weighted-average exercise price of $2.49 per share;
● 1,849,036 shares of common stock issuable upon conversion of our Series A Convertible Preferred Stock, or Series A Preferred Stock; and
● any additional shares of common stock we may issue from time to time after that date.
Unless otherwise indicated, all information in this prospectus assumes the following:
● no exercise of outstanding options and warrants (including the Warrants); and
● no conversion of outstanding shares of our Series A Preferred Stock, or our convertible notes.
5
